Nevertheless, these findings were based solely on in vitro experiments, and additional studies are necessary to elucidate how elevated levels of PRMT5 in tumor cells affect the onset and progression of cervical cancer in vivo. This evidence concerns the gene PRMT5 and neoplasm.